Combination of icotinib, surgery, and internal radiotherapy of a patient with lung cancer severely metastasized to the vertebrae bones with EGFR mutation: A case report

0Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

A 48-year-old Chinese female was referred to us regarding EGFR-mutated advanced non-small cell lung cancer, and metastasis to left scapula and vertebrae bones which caused pathological fracture at T8 and T10 thoracic vertebrae. An aggressive combined therapy with icotinib, vertebrae operation, and radioactive particle implantation and immunotherapy was proposed to prevent paraplegia, relieve pain, and control the overall and local tumor lesions. No postoperative symptoms were seen after surgery, and the pain was significantly relieved. Icotinib merited a 31-month partial response with grade 1 diarrhea as its drug-related adverse event. High dose of icotinib was administered after pelvis lesion progression for 3 months with good tolerance. Combination therapy of icotinib, surgery, and internal radiation for metastases of the vertebrae bones from non-small cell lung cancer seems to be a very promising technique both for sufficient pain relief and for local control of the tumor, vertebrae operation can be an encouraging option for patients with EFGR positive mutation and good prognosis indicator.

Cite

CITATION STYLE

APA

Qu, L. L., Qin, H. F., Gao, H. J., & Liu, X. Q. (2015). Combination of icotinib, surgery, and internal radiotherapy of a patient with lung cancer severely metastasized to the vertebrae bones with EGFR mutation: A case report. OncoTargets and Therapy, 8, 1271–1276. https://doi.org/10.2147/OTT.S80012

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free